Galmed Pharmaceuticals(GLMD) - Prospectus(update)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 AMENDMENT NO. 2 As filed with the Securities and Exchange Commission on July 12, 2023. Registration No. 333-272722 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GALMED PHARMACEUTICALS LTD. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) State of Israel 2834 Not Applicable (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Ide ...